Literature DB >> 15547097

Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

O Kasapçopur1, S Altun, M Aslan, S Karaarslan, A Kamburoglu-Göksel, S Saribas, N Arisoy, B Kocazeybek.   

Abstract

OBJECTIVE: To correlate serum anti-cyclic citrullinated peptide antibodies (anti-CCP) levels with juvenile idiopathic arthritis (JIA) subtypes and with an erosive disease course.
METHODS: The study group comprised 122 children with JIA; 16 were evaluated during both active disease and remission. Nineteen children with systemic lupus erythematosus (SLE), 27 with rheumatoid arthritis (RA), and 15 healthy children were also included in the study. Twelve children with JIA were rheumatoid factor (RF) positive, and 34 patients had persistent erosive joint disease. Anti-CCP antibody levels were determined by ELISA; values above 5 relative units were regarded as positive.
RESULTS: Three girls with seropositive polyarticular JIA and erosive joint disease had positive anti-CCP values. Children evaluated during active disease and remission, patients with SLE, and healthy children all had negative anti-CCP antibody levels. However, 19/27 (70%) adult patients with RA had positive anti-CCP antibody values.
CONCLUSIONS: In contrast with RA, anti-CCP positivity is only rarely found in patients with JIA. In patients with RF positivity and/or in patients with erosive joint disease, anti-CCP can be detected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547097      PMCID: PMC1754844          DOI: 10.1136/ard.2003.019331

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.

Authors:  Toshihiro Matsui; Kota Shimada; Shigeto Tohma
Journal:  Clin Rheumatol       Date:  2005-11-10       Impact factor: 2.980

2.  Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.

Authors:  Mihaela Spârchez; Nicolae Miu; Claudia Bolba; Mihaela Iancu; Zeno Spârchez; Simona Rednic
Journal:  Clin Rheumatol       Date:  2015-05-21       Impact factor: 2.980

3.  Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  R Gupta; M M Thabah; B Vaidya; S Gupta; R Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2010-02-05       Impact factor: 1.967

4.  A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients.

Authors:  Elham Aflaky; Saeedeh Shenavandeh; Mohammad Javad Ashraf
Journal:  Rheumatol Int       Date:  2009-08-12       Impact factor: 2.631

Review 5.  Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology.

Authors:  Reema H Syed; Brooke E Gilliam; Terry L Moore
Journal:  Curr Rheumatol Rep       Date:  2008-04       Impact factor: 4.592

6.  Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.

Authors:  Rim Sghiri; Elyes Bouagina; Hela Zaglaoui; Hajer Mestiri; Latifa Harzallah; Imed Harrabi; Mehdi Ghannouchi; Faycel Mokhtar; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2007-04-20       Impact factor: 2.631

7.  Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.

Authors:  Anne E Tebo; Troy Jaskowski; K Wayne Davis; April Whiting; Bronte Clifford; Andrew Zeft; Bernadette McNally; Harry R Hill; John Bohnsack; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-29       Impact factor: 3.054

8.  B-cell pathology in juvenile idiopathic arthritis.

Authors:  V Wiegering; H J Girschick; H Morbach
Journal:  Arthritis       Date:  2010-12-02

9.  Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis.

Authors:  Brooke E Gilliam; Melinda R Reed; Anil K Chauhan; Amanda B Dehlendorf; Terry L Moore
Journal:  Pediatr Rheumatol Online J       Date:  2011-03-25       Impact factor: 3.054

10.  Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis.

Authors:  Brooke E Gilliam; Anil K Chauhan; Terry L Moore
Journal:  Pediatr Rheumatol Online J       Date:  2013-08-29       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.